The role of ATP-binding cassette transporters in neuro-inflammation: Relevance for bioactive lipids

Frontiers in Pharmacology

Volumn 3 APR, Issue , 2012, Pages

  Kooij, Gijs ^a   Van Horssen, Jack ^a   Bandaru, Veera Venkata Ratnam ^b   Haughey, Norman J ^b   De Vries, Helga E ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Astrocytes; ATP binding cassette transporters; Bioactive lipids; Blood brain barrier; Chemokines; Multiple sclerosis; Platelet activating factor

Indexed keywords

ABC TRANSPORTER; ADENOSINE TRIPHOSPHATE; ARACHIDONIC ACID; BREAST CANCER RESISTANCE PROTEIN; CERAMIDE; LEUKOTRIENE; LIPID; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MYELIN; PROSTAGLANDIN; PROTEOLIPID PROTEIN; SPHINGOSINE 1 PHOSPHATE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ACTIVE TRANSPORT; ALLERGIC ENCEPHALOMYELITIS; ARTICLE; ASTROCYTE; BIOLOGICAL ACTIVITY; BLOOD BRAIN BARRIER; CYTOKINE RELEASE; DEMYELINATION; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HYDROLYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IMMUNOREACTIVITY; LIQUID CHROMATOGRAPHY; MACROPHAGE; MICROGLIA; MONOCYTE; MULTIPLE SCLEROSIS; NERVE CELL EXCITABILITY; NERVOUS SYSTEM INFLAMMATION; NEUROMODULATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; TIGHT JUNCTION; TISSUE INJURY;

EID: 84866006443     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2012.00074     Document Type: Article

References (58)

1. Abbott, N. J., Ronnback, L., and Hansson,E. (2006). Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7, 41-53.
2. Aronica, E., Sisodiya, S. M., and Gorter, J. A. (2011). Cerebral expression of drug transporters in epilepsy. Adv. Drug Deliv. Rev. (in press).
3. Ballou, L. R., Laulederkind, S. J., Rosloniec, E. F., and Raghow, R. (1996). Ceramide signalling and the immune response. Biochim. Biophys. Acta 1301, 273-287.
4. Bartels, A. L., Willemsen, A. T., Kortekaas, R., de Jong, B. M., de Vries, R., de Klerk, O., van Oostrom, J. C., Portman, A., and Leenders, K. L. (2008). Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA. J. Neural Transm. 115, 1001-1009.
5. Bradshaw, C. D., Ella, K. M., Thomas, A. L., Qi, C., and Meier, K. E. (1996). Effects of Ara-C on neutral sphingomyelinase and mitogenand stress-activated protein kinases in Tlymphocyte cell lines. Biochem. Mol. Biol. Int. 40, 709-719.
6. Bruck, W., Sommermeier, N., Bergmann, M., Zettl, U., Goebel, H. H., Kretzschmar, H. A., and Lassmann, H. (1996). Macrophages in multiple sclerosis. Immunobiology 195, 588-600.
7. Callea, L., Arese, M., Orlandini, A., Bargnani, C., Priori, A., and Bussolino, F. (1999). Platelet activating factor is elevated in cerebral spinal fluid and plasma of patients with relapsing-remitting multiple sclerosis. J. Neuroimmunol. 94, 212-221.
8. Comabella,M.,and Khoury,S. J. (2012). Immunopathogenesis of multiple sclerosis. Clin. Immunol. 142, 2-8.
9. Dam-Klages, S., Schwandner, R., Adam, D., Kreder, D., Bernardo, K., and Krönke, M. (1998). Distinct adapter proteins mediate acid versus neutral sphingomyelinase activation through the p55 receptor for tumor necrosis factor. J. Leukoc. Biol. 63, 678-682.
10. De Groot, C. J., Langeveld, C. H., Jongenelen, C. A., Montagne, L., Van Der Valk, P., and Dijkstra, C. D. (1997). Establishment of human adult astrocyte cultures derived from postmortem multiple sclerosis and control brain and spinal cord regions: immunophenotypical and functional characterization. J. Neurosci. Res. 49, 342-354.
11. Desai, S., and Barton, R. (1990). Role of platelet activating factor in the pathogenesis of active and passive models of experimental allergic encephalomyelitis in the rat. Agents Actions 31, 43-46.
12. Detre, C., Kiss, E., Varga, Z., Ludányi, K., Pászty, K., Enyedi, A., Kövesdi, D., Panyi, G., Rajnavölgyi, E., and Matkó, J. (2006). Death or survival: membrane ceramide controls the fate and activation of antigenspecific T-cells depending on signal strength and duration. Cell. Signal. 18, 294-306.
13. D'Souza, S. D., Bonetti, B., Balasingam, V., Cashman, N. R., Barker, P. A., Troutt, A. B., Raine, C. S., and Antel, J. P. (1996). Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J. Exp. Med. 184, 2361-2370.
14. Elkord, E., Williams, P. E., Kynaston, H., and Rowbottom, A. W. (2005). Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells. Immunology 114, 204-212.
15. Falcone, S., Perrotta, C., De Palma, C., Pisconti, A., Sciorati, C., Capobianco, A., Rovere-Querini, P., Manfredi, A. A., and Clementi, E. (2004). Activation of acid sphingomyelinase and its inhibition by the nitric oxide/cyclic guanosine 3′,5′monophosphate pathway: key events in Escherichia coli-elicited apoptosis of dendritic cells. J. Immunol. 173, 4452-4463.
16. Frank, M. H., Denton, M. D., Alexander, S. I., Khoury, S. J., Sayegh, M. H., and Briscoe, D. M. (2001). Specific MDR1 P-glycoprotein blockade inhibits human alloimmune T cell activation in vitro. J. Immunol. 166, 2451-2459.
17. Frohman, E. M., Racke, M. K., and Raine, C. S. (2006). Multiple sclerosis-the plaque and its pathogenesis. N.Engl.J.Med.354, 942-955.
18. Gsur, A., Hamilton, G., Zhao, S., Angerler, J., Fiegl, M., Zojer, N., Raderer, M., Haberl, I., Andreeff, M., and Huber, H. (1996). Involvement of Pglycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL4, and interferon-gamma in normal human T lymphocytes. Blood 88, 1747-1754.
19. Hohlfeld, R., and Wekerle, H. (2004). Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines. Proc. Natl. Acad. Sci. U.S.A. 101(Suppl. 2), 14599-14606.
20. Honda, Z., Nakamura, M., Miki, I., Minami, M., Watanabe, T., Seyama, Y., Okado, H., Toh, H., Ito, K., Miyamoto, T., and Shimizu, T. (1991). Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature 349, 342-346.
21. Huang, Y. H., Schafer-Elinder, L., Wu, R., Claesson, H. E., and Frostegard, J. (1999). Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a plateletactivating factor (PAF) receptordependent mechanism. Clin. Exp. Immunol. 116, 326-331.
22. Inokuchi, J., Mizutani, A., Jimbo, M., Usuki, S., Yamagishi, K., Mochizuki, H., Muramoto, K., Kobayashi, K., Kuroda, Y., Iwasaki, K., Ohgami, Y., and Fujiwara, M. (1997). Upregulation of ganglioside biosynthesis, functional synapse formation, and memory retention by a synthetic ceramide analog (L-PDMP). Biochem. Biophys. Res. Commun. 237, 595-600.
23. Kajimoto, T., Okada, T., Yu, H., Goparaju, S. K., Jahangeer, S., and Nakamura, S. (2007). Involvement of sphingosine-1-phosphate in glutamate secretion in hippocampal neurons. Mol. Cell. Biol. 27, 3429-3440.
24. Kihara,Y., Ishii, S., Kita,Y., Toda,A., Shimada, A., and Shimizu, T. (2005). Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor. J. Exp. Med. 202, 853-863.
25. Kooij, G., Mizee, M. R., van Horssen, J., Reijerkerk, A., Witte, M. E., Drexhage, J. A. R., van der Pol, S. M. A., van het Hof, B., Scheffer, G., Scheper, R., Dijkstra, C. D., van der Valk, P., and deVries,H. E. (2011).Adenosine triphosphate-binding cassette transporters mediate chemokine (C-C motif) ligand 2 secretion from reactive astrocytes: relevance to multiple sclerosis pathogenesis. Brain 134, 555-570.
26. Kooij, G., van Horssen, J., de Lange, E. C., Reijerkerk, A., van der Pol, S. M., van Het Hof, B., Drexhage, J., Vennegoor, A., Killestein, J., Scheffer, G., Oerlemans, R., Scheper, R., van der Valk, P., Dijkstra, C. D., and de Vries, H. E. (2010). T lymphocytes impair P-glycoprotein function during neuroinflammation. J. Autoimmun. 34, 416-425.
27. Kooij, G., Backer, R., Koning, J. J., Reijerkerk, A., van Horssen, J., Van der Pol, S. M. A., Drexhage, J., Schinkel, A., Dijkstra, C. D., den Haan, J. M. M., Geijtenbeek, T. B. H., and de Vries, H. E. (2009). P-glycoprotein acts as an immunomodulator during neuroinflammation. PLoS ONE 4, e8212. doi:10.1371/journal.pone.0008212
28. Kronke, M. (1999). Biophysics of ceramide signaling: interaction with proteins and phase transition of membranes. Chem. Phys. Lipids 101, 109-121.
29. Lagas, J. S., Sparidans, R. W., Van Waterschoot, R. A., Wagenaar, E., Beijnen, J. H., and Schinkel, A. H. (2008). P-glycoprotein limits oral availability, brain penetration, and toxicity of an anionic drug, the antibiotic salinomycin. Antimicrob. Agents Chemother. 52, 1034-1039.
30. Lage, H. (2008). An overview of cancer multidrug resistance: a still unsolved problem. Cell.Mol.Life Sci.65, 3145-3167.
31. Langford, D., Grigorian, A., Hurford, R., Adame, A., Ellis, R. J., Hansen, L., and Masliah, E. (2004). Altered P-glycoprotein expression in AIDS patients with HIV encephalitis. J. Neuropathol. Exp. Neurol. 63, 1038-1047.
32. Li, H., Cuzner, M. L., and Newcombe, J. (1996). Microglia-derived macrophages in early multiple sclerosis plaques. Neuropathol. Appl. Neurobiol. 22, 207-215.
33. Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., Klonowski, P., Austin, A., Lad, N., Kaminski, N., Galli, S. J., Oksenberg, J. R., Raine, C. S., Heller, R., and Steinman, L. (2002). Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8, 500-508.
34. Loscher, W., and Potschka, H. (2005a). Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx 2, 86-98.
35. Loscher, W., and Potschka, H. (2005b). Drug resistance in brain diseases and the role of drug efflux transporters. Nat. Rev. Neurosci. 6, 591-602.
36. Miller, D. S. (2010). Regulation of Pglycoprotein and other ABC drug transporters at the blood-brain barrier. Trends Pharmacol. Sci. 31, 246-254.
37. Montrucchio, G., Alloatti, G., and Camussi, G. (2000). Role of plateletactivating factor in cardiovascular pathophysiology. Physiol. Rev. 80, 1669-1699.
38. Norman, E., Cutler, R. G., Flannery, R., Wang, Y., and Mattson, M. P. (2010). Plasma membrane sphingomyelin hydrolysis increases hippocampal neuron excitability by sphingosine-1-phosphate mediated mechanisms. J. Neurochem. 114, 430-439.
39. Pedotti, R., De Voss, J. J., Steinman, L., and Galli, S. J. (2003). Involvement of both "allergic" and "autoimmune" mechanisms in EAE, MS and other autoimmune diseases. Trends Immunol. 24, 479-484.
40. Raggers, R. J., Vogels, I., and van, M. G. (2001). Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor. Biochem. J. 357, 859-865.
41. Randolph, G. J., Beaulieu, S., Pope, M., Sugawara, I., Hoffman, L., Steinman, R. M., and Muller, W. A. (1998). A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. Proc. Natl. Acad. Sci. U.S.A. 95, 6924-6929.
42. Rohrbough, J., Rushton, E., Palanker, L., Woodruff, E., Matthies, H. J. G., Acharya, U., Acharya, J. K., and Broadie, K. (2004). Ceramidase regulates synaptic vesicle exocytosis and trafficking. J. Neurosci. 24, 7789-7803.
43. Sisodiya, S. M., Lin, W. R., Harding, B. N., Squier, M. V., and Thom, M. (2002). Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy. Brain 125, 22-31.
44. Sofroniew, M. V. (2009). Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 32, 638-647.
45. Solomon, J. C., Sharma, K., Wei, L. X., Fujita, T., and Shi, Y. F. (2003). A novel role for sphingolipid intermediates in activation-induced cell death in T cells. Cell Death Differ. 10, 193-202.
46. Speth, C., Dierich, M. P., and Sopper, S. (2005). HIV-infection of the central nervous system: the tightrope walk of innate immunity. Mol. Immunol. 42, 213-228.
47. Stafforini, D. M., McIntyre, T. M., Zimmerman, G. A., and Prescott, S. M. (2003). Platelet-activating factor, a pleiotropic mediator of physiological and pathological processes. Crit. Rev. Clin. Lab. Sci. 40, 643-672.
48. Steinman, L. (2001). Multiple sclerosis: a two-stage disease. Nat. Immunol. 2, 762-764.
49. Tani, M., Glabinski, A. R., Tuohy, V. K., Stoler, M. H., Estes, M. L., and Ransohoff, R. M. (1996). In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis. Am. J. Pathol. 148, 889-896.
50. Van de Ven, R., De Jong, M. C., Reurs, A. W.,Schoonderwoerd,A. J.,Jansen, G., Hooijberg, J. H., Scheffer, G. L., de Gruijl, T. D., and Scheper, R. J. (2006). Dendritic cells require multidrug resistance protein 1 (ABCC1) transporter activity for differentiation. J. Immunol. 176, 5191-5198.
51. Van de Ven, R., Oerlemans, R., van der Heijden, J. W., Scheffer, G. L., de Gruijl, T. D., Jansen, G., and Scheper, R. J. (2009). ABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancer. J. Leukoc. Biol. 86, 1075-1087.
52. Van der Valk, P., and De Groot, C. J. (2000). Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. Neuropathol. Appl. Neurobiol. 26, 2-10.
53. Van Horssen, J., Bo, L., Dijkstra, C. D., and de Vries, H. E. (2006a). Extensive extracellular matrix depositions in active multiple sclerosis lesions. Neurobiol. Dis. 24, 484-491.
54. Van Horssen, J., Vos, C. M., Admiraal, L., Van Haastert, E. S., Montagne, L., Van der Valk, P., and de Vries, H. E. (2006b). Matrix metalloproteinase19 is highly expressed in active multiple sclerosis lesions. Neuropathol. Appl. Neurobiol. 32, 585-593.
55. Vogelgesang, S., Cascorbi, I., Schroeder, E., Pahnke, J., Kroemer, H. K., Siegmund,W.,Kunert-Keil,C.,Walker,L. C., and Warzok, R. W. (2002). Deposition of Alzheimer's beta-amyloid is inversely correlated with Pglycoprotein expression in the brains of elderly non-demented humans. Pharmacogenetics 12, 535-541.
56. Wheeler, D., Bandaru, V. V., Calabresi, P. A., Nath, A., and Haughey, N. J. (2008). A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis. Brain 131, 3092-3102.
57. Wheeler, D., Knapp, E., Bandaru, V. V., Wang, Y., Knorr, D., Poirier, C., Mattson, M. P., Geiger, J. D., and Haughey, N. J. (2009). Tumor necrosis factor-alpha-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors. J. Neurochem. 109, 1237-1249.
58. Wiegmann, K., Schutze, S., Machleidt, T., Witte, D., and Kronke, M. (1994). Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78, 1005-1015.